Biomarkers in whichever modality are tremendously important in diagnosing of disease,
tracking disease progression and clinical trials. This applies in particular for disorders with a …

Autophagy is the process by which cells can selectively or non-selectively remove damaged
proteins and organelles. As the cell's main means of sequestering damaged mitochondria …

Mitochondrial dysfunction is a hallmark of idiopathic neurodegenerative diseases, including
Parkinson disease, amyotrophic lateral sclerosis, Alzheimer disease and Huntington …

Objective Severe hyposmia is a risk factor of dementia in Parkinson's disease (PD), while
the underlying functional connectivity (FC) and brain volume alterations in PD patients with …

Measuring compensation in neurodegeneration using MRI : Current Opinion in Neurology
Measuring compensation in neurodegeneration using MRI : Current Opinion in Neurology Log …

Compensation is described as normal or near to normal performance in Parkinson's disease
(PD), despite the ongoing neural loss. Functional compensation typically proceeds in an …

Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by motor
symptoms such as bradykinesia, rigidity, and resting tremor. While the majority of PD cases …

The genetic analysis of early-onset Parkinsonian disorder (EOPD) is part of the clinical
diagnostics. Several genes have been implicated in the genetic background of …

Between 10 and 15% of Parkinson disease (PD) cases can be traced to a genetically
identified causative mutation which currently number over 40. This enables the study of both …

A Parkinson-kór (PD) a második leggyakoribb progresszív neurodegeneratív betegség. A
legfrissebb tanulmányok szerint körülbelül 6 millió ember érintett világszerte. A 60 éves kor …